0001437749-21-016764.txt : 20210712 0001437749-21-016764.hdr.sgml : 20210712 20210712133117 ACCESSION NUMBER: 0001437749-21-016764 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210706 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20210712 DATE AS OF CHANGE: 20210712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROCYON CORP CENTRAL INDEX KEY: 0000812306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 368732690 STATE OF INCORPORATION: CO FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-17449 FILM NUMBER: 211085200 BUSINESS ADDRESS: STREET 1: 1300 S HIGHLAND AVE CITY: CLEARWATER STATE: FL ZIP: 33756 BUSINESS PHONE: (727)447-2998 MAIL ADDRESS: STREET 1: 1300 S HIGHLAND AVE CITY: CLEARWATER STATE: FL ZIP: 33756 8-K 1 pcyn20210712_8k.htm FORM 8-K pcyn20210712_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report  
(Date of Earliest Event Reported): Commission File Number:
July 6, 2021 0-17449

 

 

PROCYON CORPORATION

(Exact name of Registrant as specified in its charter)

 

Colorado 59-3280822
(State of incorporation) (I.R.S. Employer Identification Number)

 

1300 S. HIGHLAND

CLEARWATER, FL 33756

(727) 447-2998

(Address of principal executive

offices and telephone number)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

None

None

None

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐ Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On July 6, 2021, Dr. Paul E. Kudelko, Sr. gave notice to the Board of Directors of Procyon Corporation (the “Company”) of his resignation for personal reasons, effective immediately. The Company is in the process of reviewing certain candidates to fill the vacancy.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date: July 12, 2021 Procyon Corporation  
       
       
  By: /s/ Justice W. Anderson  
    Justice W. Anderson  
    Chief Executive Officer